Scott Requadt Talaris Therapeutics, Inc. (TALS) insider trading activity

Scott Requadt is of Talaris Therapeutics, Inc.. Currently has a direct ownership of 578,403 shares of TALS, which is worth approximately $1.57 Million. The most recent transaction as insider was on Jul 03, 2023, when has been sold 11,786 shares (Common Stock) at a price of $3.08 per share, resulting in proceeds of $36,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 578K

0% 3M change

2.0% 12M change

Total Value Held $1.57 Million

Scott Requadt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 03 2023	SELL Payment of exercise price or tax liability	$36,300 $3.08 p/Share	11,786 Reduced 2.0%	578,403 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	$3 $0.87 p/Share	4 Added 0.0%	590,193 Common Stock
Sep 10 2022	BUY Grant, award, or other acquisition	-	80,000 Added 11.94%	590,189 Common Stock
Jul 29 2022	BUY Open market or private purchase	$167,374 $4.25 p/Share	39,382 Added 7.19%	508,680 Common Stock
Jul 28 2022	BUY Open market or private purchase	$13,132 $4.25 p/Share	3,090 Added 0.65%	469,298 Common Stock
Jul 26 2022	BUY Open market or private purchase	$23,439 $4.24 p/Share	5,528 Added 1.17%	466,208 Common Stock
Jul 22 2022	BUY Open market or private purchase	$35,415 $3.75 p/Share	9,444 Added 2.01%	460,680 Common Stock

Dec 31 2021	BUY Grant, award, or other acquisition	$19,110 $13.0 p/Share	1,470 Added 0.32%	451,236 Common Stock

Also insider at

EPIX

ESSA Pharma Inc. Healthcare

Scott Requadt

Louisville, KY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Value

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS

Account